Role of Ultrasound in Diagnosis of Placenta Previa and MAP

Morbidly Adherent Placenta Clinical Trial

Official title:
Evaluation of Role of Ultrasound TA,TV,TP in Diagnosis of Placenta Previa and MAP(Morbidly Adherent Placenta )

Status Completed

Clinical Trial Summary

Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.

Clinical Trial Description

The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of placenta accreta is usually severe , life-threatening hemorrhage. The recommended intervention of suspected placenta accreta is planned preterm cesarean hysterectomy with the placenta left in situ. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03416296
Study type	Observational
Source	Aljazeera Hospital
Contact
Status	Completed
Phase
Start date	March 15, 2018
Completion date	December 20, 2019

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05817448` - Hypoxia-induced Autophagy in the Pathogenesis of MAP
Active, not recruiting	`NCT02784886` - Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta	N/A
Recruiting	`NCT03676855` - Comparison Between Bladder Dissection Before and After Uterine Incision in Cesarean Section for Morbidly Adherent Placenta	N/A
Withdrawn	`NCT02635412` - Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial	N/A
Recruiting	`NCT04938050` - Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings
Completed	`NCT03976453` - Psychological Outcome of Women With Morbidly Adherent Placenta Following Hystrectomy
Recruiting	`NCT05307016` - Morbidly Adherent Placenta, Diagnosis and Proper Management